Generated by Meeveem AI
"Global leader in medical device testing, research and regulatory compliance"
NAMSA serves over 3,000 medical device and IVD manufacturers worldwide, conducting testing, preclinical research, clinical trials, and regulatory consulting for more than 100,000 devices annually. Founded in 1967, the company operates GLP-compliant facilities across North America, Europe, and Asia. NAMSA's expertise spans all device risk classes, with results trusted by the US FDA, EU Notified Bodies, and global authorities. Manufacturers gain a holistic regulatory roadmap by consolidating testing, clinical trials, and compliance services under one partner. This integrated approach shortens time to market, increases approval success, and reduces costs through direct oversight and seamless coordination across all development phases.
1700
Team Members
1967
Founded
Contract Research
Sector
Hybrid
Work Environment
A future where medical device innovation accelerates patient care globally, with every new technology reaching the market safely, efficiently, and with proven clinical efficacy that transforms lives.
Deliver best in class global MedTech solutions through our people, expertise, and technology.